Author:
Moreno-Bost Amberly,Szmania Susann,Stone Katie,Garg Tarun,Hoerring Antje,Szymonifka Jackie,Shaughnessy John,Barlogie Bart,Grant Prentice H.,van Rhee Frits
Subject
Cancer Research,Transplantation,Cell Biology,Genetics (clinical),Oncology,Immunology,Immunology and Allergy
Reference56 articles.
1. A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1;Shaughnessy;Blood,2007
2. Multi-center, double blind, randomized, placebo-controlled phase II study to assess the efficacy of recombinant MAGE-A3 vaccine as adjuvant therapy in stage IB/II MAGE-A3 positive, completely resected, non-small cell lung cancer (NSCLC);Vansteenkiste;J Clin Oncol,2006
3. Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma;Dudley;J Clin Oncol,2005
4. The cancer germ-line genes MAGE-1, MAGE-3 and PRAME are commonly expressed by human myeloma cells;Pellat-Deceunynck;Eur J Immunol,2000
5. Genes encoding tumor-specific antigens are expressed in human myeloma cells;van Baren;Blood,1999
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献